Metabolic Syndrome and Physical Decline in Older Persons: Results from the Health, Aging and Body Composition Study

EMGO Institute/Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
The Journals of Gerontology Series A Biological Sciences and Medical Sciences (Impact Factor: 5.42). 01/2009; 64(1):96-102. DOI: 10.1093/gerona/gln005
Source: PubMed


The metabolic syndrome includes dyslipidemia, abdominal obesity, insulin resistance, and hypertension and is associated with an increased risk of diabetes and cerebrovascular disease (CVD), but consequences beyond these outcomes have not been examined extensively. We investigated whether metabolic abnormalities have independent consequences on loss of mobility function of older persons.
Data are from 2,920 men and women, 70-79 years, participating in the Health ABC study without mobility limitations at baseline. Metabolic syndrome was defined as > or =3 of the following: (a) waist circumference >102 (men) or >88 cm (women); (b) triglycerides > or =150 mg/dL; (c) high-density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women); (d) blood pressure > or =130/85 mm Hg or antihypertensive medication; and (d) fasting glucose > or =110 mg/dL or antidiabetic medication. Mobility limitation was defined as difficulty or inability walking (1/4) mile or climbing 10 steps during two consecutive semiannual assessments over 4.5 years.
The prevalence of metabolic syndrome was 38.6%. The metabolic syndrome was associated with an adjusted relative risk (RR) of 1.46 (95% confidence interval [CI] = 1.30-1.63) for developing mobility limitations. The risk increased when more metabolic syndrome components were present (p trend >.001). All metabolic syndrome components were significantly associated with incident mobility limitations with the highest RRs for abdominal obesity (RR = 1.54, 95% CI = 1.35-1.75) and hyperglycemia (RR = 1.44, 95% CI = 1.27-1.63). Findings were unchanged when persons with baseline, or incident, CVD, stroke, or diabetes were excluded.
Metabolic syndrome abnormalities, especially abdominal obesity and hyperglycemia, are predictive of mobility limitations in the elderly, independent of CVD or diabetes.

5 Reads
  • Source
    • "In general, it is thought that insulin resistance and hyperinsulinemia increase with aging (Lin et al. 2011; Frisardi et al. 2010; Barzilai et al. 2012; Penninx et al. 2009), that in the elderly, obesity-and insulin-resistant individuals are more long lived, and that mortality in the elderly could lead to the retention of obesity-and insulin-resistant individuals (Lamming et al. 2012; Blanchard 2005; Andres 1980). However, our results in this study of long-lived subjects provide contradictory evidence. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we examined the association of fasting serum insulin (FSI) and fasting serum glucose (FSG) with cognitive impairment in the very elderly using a sample of Chinese nonagenarians/centenarians. This study used data from a survey that was conducted in 2005 on all residents aged 90 years or more in a district with 2,311,709 inhabitants. FSG, FSI, and cognitive function were analyzed. The sample included 661 unrelated Chinese individuals (aged 90-108 years; mean, 93.52 ± 3.37 years; 67.17 % women; FSI, 6.27 ± 2.27 mU/mL; FSG levels, 4.46 ± 1.45 mmol/L). The prevalence of cognitive impairment was 61.81 % and that of hypoinsulinemia was 31.92 %. Individuals with hypoinsulinemia showed lower cognitive function scores (14.81 ± 5.79 vs. 15.78 ± 5.24, t = 2.160, P = 0.031). No differences in cognitive function score between different FSI and FSG groups were significant, and no differences in FSI and FSG between individuals with and without cognitive impairment were statistically significant. Unadjusted multiple logistic regressions showed that hypoinsulinemia, impaired fasting glucose, or diabetes did not change the risk of cognitive impairment significantly. In summary, we found that in elderly subjects, cognitive function appeared associated with FSI, and higher FSI may be associated with enhanced cognitive function.
    Age 06/2013; 36(1). DOI:10.1007/s11357-013-9547-6 · 3.45 Impact Factor
  • Source
    • "However, previous studies are limited in that they have not measured cognitive function comprehensively. Most of previous studies have applied simple tests, such as the Mini-Mental State Examination (MMSE), to the evaluation of cognitive function and have not accurately assessed early dementia or mild cognitive disorder.14,15) The MMSE is a simple method that is high in sensitivity and specificity, but it is limited in measuring cognitive function comprehensively. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic syndrome has been reported to have adverse effects on cognitive function, although the results are conflicting. The purpose of this study was to examine the relationship between metabolic syndrome and cognitive function in elderly Korean participants older than 60 years. We examined elderly participants who visited the health promotion center in Gyeonggi-do province. We categorized the participants into two groups based on the presence of metabolic syndrome (48 participants in the metabolic syndrome group and 45 in the control group). Cognitive function was assessed in all participants using the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-K). Compared with those without metabolic syndrome, participants with metabolic syndrome had lower mean total CERAD-K scores (64.2 ± 11.1 vs. 69.8 ± 9.2, P = 0.010). In the comparison of CERAD-K items, significantly lower scores were observed in the verbal fluency test, the construction recall test, the word list learning test, and trail making B in the group with metabolic syndrome. After controlling age, sex, education, smoking, alcohol, physical activity and the Korean version of the Short Geriatric Depression Scale of Korean, multiple regression analysis showed that metabolic syndrome was independently associated with cognitive function (P = 0.014). Alcohol intake (P = 0.002) and education years (P = 0.001) were also contributing factors to cognitive function. This study found a significant relationship between cognitive function and metabolic syndrome. It will be necessary to perform a prospective study to determine whether metabolic syndrome causes cognitive dysfunction or if the correction of metabolic syndrome can improve cognitive function.
    09/2011; 32(6):358-66. DOI:10.4082/kjfm.2011.32.6.358
  • Source
    • "Older flies had 9% more TAG (the least squared mean for 1-week-old flies was 7.65 mg=fly, and for 4-week- old flies was 8.43 mg=fly). Age-related increase in TAG levels are common in mammals (e.g., Tucker and Turcotte, 2003) and are one of the hallmarks of metabolic syndrome in aged humans (Kong et al., 2006; Penninx et al., 2009). Flies on DR had 2% less TAG than those on the STD diet (the least squared mean for flies on the STD diet was 8.12 mg=fly, and for those on DR was 7.96 mg=fly). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Life history theory hypothesizes that genetically based variation in life history traits results from alleles that alter age-specific patterns of energy allocation among the competing demands of reproduction, storage, and maintenance. Despite the important role that alleles with age-specific effects must play in life history evolution, few naturally occurring alleles with age-specific effects on life history traits have been identified. A recent mapping study identified S6 kinase (S6k) as a candidate gene affecting lipid storage in Drosophila. S6k is in the target of rapamycin pathway, which regulates cell growth in response to nutrient availability and has also been implicated to influence many life history traits from fecundity to life span. In this article, we used quantitative complementation tests to examine the effect of allelic variation at S6k on a range of phenotypes associated with metabolism and fitness in an age-, diet-, and sex-specific manner. We found that alleles of S6k have pleiotropic effects on total protein levels, glycogen storage, life span, and the immune response and demonstrate that these allelic effects are age, diet, and sex specific. As many of the genes in the target of rapamycin pathway are evolutionarily conserved, our data suggest that genes in this pathway could play a pivotal role in life history evolution in a wide range of taxa.
    DNA and cell biology 09/2010; 29(9):473-85. DOI:10.1089/dna.2009.0997 · 2.06 Impact Factor
Show more


5 Reads
Available from